Characteristics of malignant pleural mesothelioma in women

Annals of Thoracic Surgery

Volumn 90, Issue 3, 2010, Pages 949-956

  Wolf, Andrea S ^a   Richards, William G ^a   Tilleman, Tamara R ^a   Chirieac, Lucian ^a   Hurwitz, Shelley ^a   Bueno, Raphael ^a   Sugarbaker, David J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENCE; AGE; ANEMIA; ARTICLE; CANCER STAGING; COHORT ANALYSIS; EPITHELIUM TUMOR; FEMALE; GENDER; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; LABORATORY; LEUKOCYTOSIS; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; PLEURA MESOTHELIOMA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX ROLE; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTOSIS; ADOLESCENT; ADULT; AGED; COMPARATIVE STUDY; MESOTHELIOMA; MIDDLE AGED; MORTALITY; PLEURA TUMOR; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 77956141404     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.04.110     Document Type: Article

References (20)

1. D.J. Sugarbaker Multimodality management of malignant pleural mesothelioma: Introduction Semin Thorac Cardiovasc Surg 21 2009 95 96
2. D.J. Sugarbaker, R.M. Flores, and M.T. Jaklitsch Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients J Thorac Cardiovasc Surg 117 1999 54 63
3. N. Merritt, C.J. Blewett, J.D. Miller, W.F. Bennett, J.E. Young, and J.D. Urschel Survival after conservative (palliative) management of pleural malignant mesothelioma J Surg Oncol 78 2001 171 174
4. J. Kukreja, M.T. Jaklitsch, D.C. Wiener, D.J. Sugarbaker, S. Burgers, and P. Baas Malignant pleural mesothelioma: overview of the North American and European experience Thorac Surg Clin 14 2004 435 445
5. K. Antman, R. Shemin, and L. Ryan Malignant mesothelioma: Prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 19651985 J Clin Oncol 6 1988 147 153
6. R.M. Flores, M. Zakowski, and E. Venkatraman Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center J Thorac Oncol 2 2007 957 965
7. A. Marinaccio, M. Nesti Regional Operational Centers Analysis of survival of mesothelioma cases in the Italian register (ReNaM) Eur J Cancer 39 2003 1290 1295
8. J.E. Herndon, M.R. Green, A.P. Chahinian, J.M. Corson, Y. Suzuki, and N.J. Vogelzang Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B Chest 113 1998 723 731
9. R. Bueno, J. Reblando, J. Glickman, M.T. Jaklitsch, J.M. Lukanich, and D.J. Sugarbaker Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma Ann Thorac Surg 78 2004 1774 1776
10. W.G. Richards, J.J. Godleski, and B.Y. Yeap Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases Cancer 116 2010 1510 1517
11. F.L. Greene, D.L. Page, I.D. Fleming, AJCC Cancer Staging Manual 6th Ed. 2002 Springer-Verlag New York
12. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours 6th Ed. 2002 Wiley-Liss New York
13. R.M. Flores, H.I. Pass, and V.E. Seshan Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients J Thorac Cardiovasc Surg 135 2008 620 626
14. R. Spirtas, R.R. Connelly, and M.A. Tucker Survival patterns for malignant mesothelioma: the SEER experience Int J Cancer 41 1988 525 530
15. V.W. Rusch, and E.S. Venkatramann Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically Ann Thorac Surg 68 1999 1799 1804
16. D. Curran, T. Sahmoud, P. Therasse, J. van Meerbeeck, P.E. Postmus, and G. Giaccone Prognostic factors in patients with pleural mesothelioma: The European Organization for Research and Treatment of Cancer Experience J Clin Oncol 16 1998 145 152
17. A.S. Alberts, G. Falkson, L. Goedhals, D.A. Vorobiof, and C.A. Van der Merwe Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers J Clin Oncol 6 1988 527 535 (Pubitemid 18090702)
18. J.M. Corson Pathology of mesothelioma Thorac Surg Clin 14 2004 447 460
19. Richards WG, Godleski JG, Katler M, Mueller J, Sugarbaker DJ. Asbestos bodies in lung tissue are associated with pathologic features and patient outcome for epithelial but not non-epithelial mesothelioma treated by extrapleural pneumonectomy. Paper presented at: American Society of Investigative Pathology, New Orleans, LA, April 1821, 2009.
20. G. Pinton, E. Brunelli, and B. Murer Estrogen receptor-β affects the prognosis of human malignant pleural mesothelioma Cancer Res 69 2009 4598 4604